Spl-ampho-lipo-structure (Spl Ampho Lipo Structure)
Amphotericin B Injectable, Liposomal
Product Images NDC 62756-954
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 62756-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-amphotercin-structure (Spl Amphotercin Structure)
Spl-carton-label (Spl Carton Label)
This text provides details about a medication named Ezchvial containing the active ingredient amphotericin B liposome for infection. The formulation contains specific liposomal membrane components, buffers, and preservatives. Instructions for usage, dosages, and storage are provided along with the manufacturer and distributor information. It emphasizes that amphotericin B liposome for injection is not interchangeable with other similar products and should only be used for intravenous infusion. The text also mentions the registration trademark and additional safety precautions.*
Spl-figure1 (Spl Figure1)
This text provides information about a study comparing the mean change in levels (mg/dL) among two groups receiving different treatments: Amphotericin B Liposome for Injection 3 mg/kg/day (n = 343) and Amphotericin B 0.6 mg/kg/day (n = 344).*
Spl-figure2 (Spl Figure2)
This text provides information about the mean creatinine concentration in mg/dL for patients who had a pretreatment value greater than 1.7 mg/dL. The data seems to include episodes tracked over several days with corresponding creatinine concentrations.*
Spl-vial-label (Spl Vial Label)
This text contains information about a medication called Amphotericin B Liposome for Injection. It provides details such as the ingredients, dosage, administration guidelines, storage instructions, and manufacturer information. Note that it should be reconstituted and diluted for intravenous use, and is sterile and preservative-free. The text also mentions non-interchangeability with other Amphotericin B products. Overall, it is a clear and detailed description of the medication for healthcare professionals or patients who may be prescribed this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
